Interpharm Holdings, Inc. Stock

Stocks

IPAH

US4605881063

Pharmaceuticals

OTC Markets Traded
Market Closed - 15:26:41 2023-06-14 EDT 5-day change 1st Jan Change
0.001000 USD +900.00% Intraday chart for Interpharm Holdings, Inc. +99,900.00% +99,900.00%
1 week+99,900.00%
Current month+99,900.00%

Valuation: Interpharm Holdings, Inc.

Market Cap 1.07M 931K 879K 798K 1.5M 102M 1.5M 10.53M 4.06M 52.09M 4.01M 3.92M 168M P/E 2006
-9.26x
P/E 2007 -4.96x
Enterprise Value 27.54M 24.02M 22.68M 20.59M 38.58M 2.64B 38.74M 272M 105M 1.34B 103M 101M 4.32B EV / Sales 2006
1.63x
EV / Sales 2007 1.47x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
1 day+900.00%
1 week+99,900.00%
Current month+99,900.00%
1 month+99,900.00%
3 months+9,900.00%
6 months+99,900.00%
Current year+99,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.01
10 years 0
Extreme 1.0E-6
0.02
Change 5-day change 1-year change 3-year change Capi.($)
+900.00%+99,900.00%+99,900.00%+99,900.00% 66
+0.04%+3.34%+53.32%+102.40% 1,028B
-0.09%+1.66%+53.24%+65.73% 651B
-0.02%+2.66%+18.65%+71.84% 466B
+0.55%-0.66%+32.42%+43.00% 346B
+0.53%+1.58%+17.72%+24.82% 266B
-0.58%+2.24%+8.05%+14.15% 259B
+1.55%+2.20%+35.12%+42.07% 208B
-4.55%-3.91%-29.68%-58.05% 191B
-0.52%+4.45%+31.57%+97.98% 186B
Average +89.69%+2.93%+10,012.04%+10,030.39% 360.17B
Weighted average by Cap. -0.13%+3.09%+34.34%+61.80%

Financials

2006 2007
Net sales 63.36M 55.25M 52.16M 47.37M 88.75M 6.08B 89.12M 625M 241M 3.09B 238M 233M 9.94B 75.59M 65.91M 62.24M 56.51M 106M 7.25B 106M 745M 288M 3.69B 284M 278M 11.86B
Net income -3.79M -3.3M -3.12M -2.83M -5.31M -364M -5.33M -37.38M -14.42M -185M -14.24M -13.92M -595M -14.06M -12.26M -11.57M -10.51M -19.69M -1.35B -19.78M -139M -53.5M -686M -52.81M -51.64M -2.21B
Net Debt 14.2M 12.38M 11.69M 10.62M 19.89M 1.36B 19.98M 140M 54.05M 693M 53.34M 52.16M 2.23B 26.47M 23.08M 21.8M 19.79M 37.08M 2.54B 37.24M 261M 101M 1.29B 99.45M 97.24M 4.16B
Logo Interpharm Holdings, Inc.
Interpharm Holdings, Inc., through its wholly owned subsidiary, Interpharm, Inc., is engaged in the business of developing, manufacturing and marketing generic prescription strength and over-the-counter pharmaceuticals. The Company sells its products under its own label to the major retailers, wholesalers, managed care organizations and national distributors, and under private label to wholesalers, distributors, repackagers and other manufacturers. During the fiscal year ended June 30, 2007 (fiscal 2007), the Company manufactured and marketed 36 generic pharmaceutical products, which represent various oral dosage strengths for 11 products and different dosage strengths for 25 of these products.
Employees
670
  1. Stock Market
  2. Stocks
  3. IPAH Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!